Life sciences & health care M&A update: Q4 2017
Digital Health technologies are driving innovation across the health care continuum and are expected to play a continued role in driving M&A activity across the sector. This Life sciences & health care M&A update provides Deloitte Corporate Finance LLC insights and market data analysis that shed light on M&A trends in the life sciences and health care industry.
Digital health: Trends and transformations
Digital Health, which constitutes a wide spectrum of technological innovations related to creating, capturing, analyzing, and sharing
- More effective patient outcomes
- Cost efficiency for
- Opportunities for continued innovation
Implementing and leveraging advances in new Digital Health solutions is expected to play a continued role in driving M&A activity across the life sciences and
- Focus on value-centric health care delivery: Value-based market forces are driving point-of-care to more cost-effective treatment sites such as Home Health or Telehealth solutions, which are typically more inclined to utilize Digital Health. A recent poll of
health careexecutives substantiates this M&A driver, with 57 percent reporting a need in finding new approaches to reduce costs through analytics-driven health care delivery methods1.
- Consumer adoption of digital health: Digital Health solutions, such as patient engagement smartphone apps and wearable devices, can increase patient and provider connectivity and lead to more effective preventative care alternatives. A recent survey indicated that 46 percent of consumers are considered active Digital Health adopters, up from 19 percent in 20152.
- Accessible health care information:
Health careproviders are utilizing advanced Digital Health platforms, such as electronic health records systems, that enable more efficient care methods and patient tracking, a trend exemplified by 96 percent of hospitals now using certified electronic health record systems3.
This newsletter is a periodic compilation of certain capital markets information. Information contained in this newsletter should not be construed as a recommendation to sell or a recommendation to buy any security. Any reference to or omission of any reference to any company in this newsletter shall not be construed as a recommendation to sell, buy or take any other action with respect to any security of any such company. We are not soliciting any action with respect to any security or company based on this newsletter. This newsletter is published solely for the general information of clients and friends of Deloitte Corporate Finance LLC. It does not take into account the particular investment objectives, financial situation, or needs of individual recipients. Certain transactions, including those involving early stage companies, give rise to substantial risk and are not suitable for all investors. This newsletter is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. Prediction of future events is inherently subject to both known risks, uncertainties and other factors that may cause actual results to vary materially. We are under no obligation to update the information contained in this newsletter. We and our affiliates and related entities, partners, principals, directors, and employees, including persons involved in the preparation or issuance of this newsletter, may from time to time have “long” and “short” positions in, and buy or sell, the securities, or derivatives (including options) thereof, of companies mentioned herein. The companies mentioned in this newsletter may be: (i) investment banking clients of Deloitte Corporate Finance LLC; or (ii) clients of Deloitte Financial Advisory Services LLP and its related entities. The decision to include any company for mention or discussion in this newsletter is wholly unrelated to any audit or other services that Deloitte Corporate Finance LLC may provide or to any audit services or any services that any of its affiliates or related entities may provide to such company. No part of this newsletter may be copied or duplicated in any form by any means, or redistributed without the prior written consent of Deloitte Corporate Finance LLC.
1 "What 183 C-suite executives told us about their top concerns,” Advisory Board. May 2017.
2 “[Rock Health] Survey: 46 Percent of Consumers Now Active Digital Health Adopters,” Healthcare Informatics. December 2016.
3 “Adoption of Electronic Health Record Systems among U.S. Non-Federal Acute Care Hospitals: 2008-2015,” Healthcare Informatics. May 2016.